A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy

Clinical trial NCT01275521 · COMPLETED

Trial details

NCT number: NCT01275521
Sponsor: University Hospital, Bordeaux
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostatic Hyperplasia

Start date: 2011-01-10
Primary completion: 2015-04-28
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.